speb/financial-data huggingface dataset:
HBIO income_statement (quarterly, 2025-03-31) — +Total Revenue: 21774000.00
HBIO balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 4808000.00
HBIO balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 13479000.00
HBIO balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 237104000.00
HBIO balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -241000.00
HBIO income_statement (quarterly, 2025-03-31) — Amortization: 1160000.00
HBIO cash_flow (quarterly, 2025-03-31) — Amortization Cash Flow: 1204000.00
HBIO cash_flow (quarterly, 2025-03-31) — Amortization Of Intangibles: 1204000.00
HBIO income_statement (quarterly, 2025-03-31) — Amortization Of Intangibles Income Statement: 1160000.00
HBIO cash_flow (quarterly, 2025-03-31) — Asset Impairment Charge: 47951000.00
HBIO income_statement (quarterly, 2025-03-31) — Basic Average Shares: 4410000.00
HBIO income_statement (quarterly, 2025-03-31) — Basic EPS: -11.42
HBIO cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 4108000.00
HBIO cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -683000.00
HBIO cash_flow (quarterly, 2025-03-31) — Capital Expenditure Reported: -170000.00
HBIO balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 8649000.00
HBIO balance_sheet (quarterly, 2025-03-31) — Capital Stock: 442000.00
HBIO balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 5546000.00
HBIO balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 5546000.00
HBIO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -1204000.00
HBIO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -683000.00
HBIO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: 2986000.00
HBIO cash_flow (quarterly, 2025-03-31) — Change In Account Payable: 1472000.00
HBIO cash_flow (quarterly, 2025-03-31) — Change In Inventory: 670000.00
HBIO cash_flow (quarterly, 2025-03-31) — Change In Other Current Assets: 29000.00
HBIO cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: -97000.00
HBIO cash_flow (quarterly, 2025-03-31) — Change In Payable: 1472000.00
HBIO cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: 1472000.00
HBIO cash_flow (quarterly, 2025-03-31) — Change In Receivables: 1438000.00
HBIO cash_flow (quarterly, 2025-03-31) — Change In Working Capital: 3512000.00
HBIO cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: 1438000.00
HBIO cash_flow (quarterly, 2025-03-31) — Changes In Cash: 1099000.00
HBIO balance_sheet (quarterly, 2025-03-31) — Common Stock: 442000.00
HBIO balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 14835000.00
HBIO income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 9590000.00
HBIO balance_sheet (quarterly, 2025-03-31) — Current Assets: 44902000.00
HBIO balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 1419000.00
HBIO balance_sheet (quarterly, 2025-03-31) — Current Debt: 35958000.00
HBIO balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 37377000.00
HBIO balance_sheet (quarterly, 2025-03-31) — Current Deferred Liabilities: 3427000.00
HBIO balance_sheet (quarterly, 2025-03-31) — Current Deferred Revenue: 3427000.00
HBIO balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 55603000.00
HBIO cash_flow (quarterly, 2025-03-31) — Deferred Income Tax: -523000.00
HBIO cash_flow (quarterly, 2025-03-31) — Deferred Tax: -523000.00
HBIO cash_flow (quarterly, 2025-03-31) — Depreciation: 451000.00
HBIO cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 1655000.00
HBIO income_statement (quarterly, 2025-03-31) — Depreciation Amortization Depletion Income Statement: 1160000.00
HBIO cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 1655000.00
HBIO income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 1160000.00
HBIO income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 4410000.00
HBIO income_statement (quarterly, 2025-03-31) — Diluted EPS: -11.42
HBIO income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -50340000.00
HBIO income_statement (quarterly, 2025-03-31) — EBIT: -49861000.00
HBIO income_statement (quarterly, 2025-03-31) — EBITDA: -48206000.00
HBIO cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: 339000.00
HBIO cash_flow (quarterly, 2025-03-31) — End Cash Position: 5546000.00
HBIO cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -1204000.00
HBIO balance_sheet (quarterly, 2025-03-31) — Finished Goods: 5128000.00
HBIO cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 2303000.00
HBIO balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -14361000.00
HBIO income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 5185000.00
HBIO balance_sheet (quarterly, 2025-03-31) — Goodwill: 8960000.00
HBIO balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 19090000.00
HBIO balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 13720000.00
HBIO balance_sheet (quarterly, 2025-03-31) — Gross PPE: 12292000.00
HBIO income_statement (quarterly, 2025-03-31) — Gross Profit: 12184000.00
HBIO income_statement (quarterly, 2025-03-31) — Impairment Of Capital Assets: 47951000.00
HBIO cash_flow (quarterly, 2025-03-31) — Income Tax Paid Supplemental Data: 2000.00
HBIO income_statement (quarterly, 2025-03-31) — Interest Expense: 933000.00
HBIO income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 933000.00
HBIO cash_flow (quarterly, 2025-03-31) — Interest Paid Supplemental Data: 799000.00
HBIO balance_sheet (quarterly, 2025-03-31) — Inventory: 22816000.00
HBIO balance_sheet (quarterly, 2025-03-31) — Invested Capital: 50793000.00
HBIO cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -683000.00
HBIO cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 0.00
HBIO balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 7230000.00
HBIO balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 7230000.00
HBIO balance_sheet (quarterly, 2025-03-31) — Net Debt: 30412000.00
HBIO income_statement (quarterly, 2025-03-31) — Net Income: -50340000.00
HBIO income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -50340000.00
HBIO income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -50340000.00
HBIO income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -50340000.00
HBIO income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -50340000.00
HBIO cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -50340000.00
HBIO income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -50340000.00
HBIO income_statement (quarterly, 2025-03-31) — Net Interest Income: -933000.00
HBIO cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: 0.00
HBIO cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: -1000000.00
HBIO income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -933000.00
HBIO cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -204000.00
HBIO balance_sheet (quarterly, 2025-03-31) — Net PPE: 12292000.00
HBIO cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -513000.00
HBIO cash_flow (quarterly, 2025-03-31) — Net Short Term Debt Issuance: -1000000.00
HBIO balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: -4255000.00
HBIO balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 717000.00
HBIO balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 717000.00
HBIO income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 9000.00
HBIO income_statement (quarterly, 2025-03-31) — Normalized Income: -2558935.00
HBIO cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 2986000.00
HBIO income_statement (quarterly, 2025-03-31) — Operating Income: -1453000.00
HBIO income_statement (quarterly, 2025-03-31) — Operating Revenue: 21774000.00
HBIO balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 4421374.00
HBIO balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 3061000.00
HBIO balance_sheet (quarterly, 2025-03-31) — Other Current Borrowings: 35958000.00
HBIO balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 8112000.00
HBIO balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: -14361000.00
HBIO income_statement (quarterly, 2025-03-31) — Other Gand A: 5185000.00
HBIO income_statement (quarterly, 2025-03-31) — Other Income Expense: -48408000.00
HBIO balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 10130000.00
HBIO cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 131000.00
HBIO balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 3517000.00
HBIO balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 1416000.00
HBIO income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: -193000.00
HBIO balance_sheet (quarterly, 2025-03-31) — Other Properties: 12292000.00
HBIO income_statement (quarterly, 2025-03-31) — Other Special Charges: 171000.00
HBIO balance_sheet (quarterly, 2025-03-31) — Payables: 4808000.00
HBIO balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 4808000.00
HBIO balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 1879000.00
HBIO balance_sheet (quarterly, 2025-03-31) — Preferred Stock: 0.00
HBIO income_statement (quarterly, 2025-03-31) — Pretax Income: -50794000.00
HBIO cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 0.00
HBIO cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -513000.00
HBIO balance_sheet (quarterly, 2025-03-31) — Raw Materials: 14671000.00
HBIO balance_sheet (quarterly, 2025-03-31) — Receivables: 13479000.00
HBIO income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 9095000.00
HBIO income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 1655000.00
HBIO cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -1000000.00
HBIO income_statement (quarterly, 2025-03-31) — Research And Development: 2321000.00
HBIO income_statement (quarterly, 2025-03-31) — Restructuring And Mergern Acquisition: 93000.00
HBIO balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -208350000.00
HBIO cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 0.00
HBIO income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 4971000.00
HBIO income_statement (quarterly, 2025-03-31) — Selling General And Administration: 10156000.00
HBIO balance_sheet (quarterly, 2025-03-31) — Share Issued: 4421374.00
HBIO cash_flow (quarterly, 2025-03-31) — Short Term Debt Issuance: 0.00
HBIO cash_flow (quarterly, 2025-03-31) — Short Term Debt Payments: -1000000.00
HBIO income_statement (quarterly, 2025-03-31) — Special Income Charges: -48215000.00
HBIO cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 600000.00
HBIO balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 14835000.00
HBIO balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: -4255000.00
HBIO income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: -433935.00
HBIO income_statement (quarterly, 2025-03-31) — Tax Provision: -454000.00
HBIO income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.01
HBIO balance_sheet (quarterly, 2025-03-31) — Total Assets: 79801000.00
HBIO balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 14835000.00
HBIO balance_sheet (quarterly, 2025-03-31) — Total Debt: 44607000.00
HBIO balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 14835000.00
HBIO income_statement (quarterly, 2025-03-31) — Total Expenses: 23227000.00
HBIO balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 64966000.00
HBIO balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 34899000.00
HBIO balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 9363000.00
HBIO income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: -49668000.00
HBIO income_statement (quarterly, 2025-03-31) — Total Unusual Items: -48215000.00
HBIO income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: -48215000.00
HBIO balance_sheet (quarterly, 2025-03-31) — Work In Process: 3017000.00
HBIO balance_sheet (quarterly, 2025-03-31) — Working Capital: -10701000.00
HBIO income_statement (quarterly, 2025-06-30) — +Operating Expense: 12152000.00
HBIO income_statement (quarterly, 2025-06-30) — +Total Revenue: 20450000.00
HBIO balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 4722000.00
HBIO balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 11937000.00
HBIO balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 237622000.00
HBIO balance_sheet (quarterly, 2025-06-30) — Allowance For Doubtful Accounts Receivable: -164000.00
HBIO income_statement (quarterly, 2025-06-30) — Amortization: 1162000.00
HBIO cash_flow (quarterly, 2025-06-30) — Amortization Cash Flow: 1205000.00
HBIO cash_flow (quarterly, 2025-06-30) — Amortization Of Intangibles: 1205000.00
HBIO income_statement (quarterly, 2025-06-30) — Amortization Of Intangibles Income Statement: 1162000.00
HBIO cash_flow (quarterly, 2025-06-30) — Asset Impairment Charge: 0.00
HBIO income_statement (quarterly, 2025-06-30) — Basic Average Shares: 4430300.00
HBIO income_statement (quarterly, 2025-06-30) — Basic EPS: -0.50
HBIO cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 5546000.00
HBIO cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -233000.00
HBIO cash_flow (quarterly, 2025-06-30) — Capital Expenditure Reported: -144000.00
HBIO balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 8450000.00
HBIO balance_sheet (quarterly, 2025-06-30) — Capital Stock: 445000.00
HBIO balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 7442000.00
HBIO balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 7442000.00
HBIO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -1258000.00
HBIO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -233000.00
HBIO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 2755000.00
HBIO cash_flow (quarterly, 2025-06-30) — Change In Account Payable: 302000.00
HBIO cash_flow (quarterly, 2025-06-30) — Change In Inventory: 977000.00
HBIO cash_flow (quarterly, 2025-06-30) — Change In Other Current Assets: 24000.00
HBIO cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: -308000.00
HBIO cash_flow (quarterly, 2025-06-30) — Change In Payable: 302000.00
HBIO cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 302000.00
HBIO cash_flow (quarterly, 2025-06-30) — Change In Receivables: 1794000.00
HBIO cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 2789000.00
HBIO cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: 1794000.00
HBIO cash_flow (quarterly, 2025-06-30) — Changes In Cash: 1264000.00
HBIO balance_sheet (quarterly, 2025-06-30) — Common Stock: 445000.00
HBIO balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 15733000.00
HBIO income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 8917000.00
HBIO balance_sheet (quarterly, 2025-06-30) — Current Assets: 44969000.00
HBIO balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 1453000.00
HBIO balance_sheet (quarterly, 2025-06-30) — Current Debt: 34864000.00
HBIO balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 36317000.00
HBIO balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 3143000.00
HBIO balance_sheet (quarterly, 2025-06-30) — Current Deferred Revenue: 3143000.00
HBIO balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 55202000.00
HBIO cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: -50000.00
HBIO cash_flow (quarterly, 2025-06-30) — Deferred Tax: -50000.00
HBIO cash_flow (quarterly, 2025-06-30) — Depreciation: 411000.00
HBIO cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 1616000.00
HBIO income_statement (quarterly, 2025-06-30) — Depreciation Amortization Depletion Income Statement: 1162000.00
HBIO cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 1616000.00
HBIO income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 1162000.00
HBIO income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 4430300.00
HBIO income_statement (quarterly, 2025-06-30) — Diluted EPS: -0.50
HBIO income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -2282000.00
HBIO income_statement (quarterly, 2025-06-30) — EBIT: -1463000.00
HBIO income_statement (quarterly, 2025-06-30) — EBITDA: 153000.00
HBIO cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: 632000.00
HBIO cash_flow (quarterly, 2025-06-30) — End Cash Position: 7442000.00
HBIO cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -1258000.00
HBIO balance_sheet (quarterly, 2025-06-30) — Finished Goods: 5935000.00
HBIO cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 2522000.00
HBIO balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -11702000.00
HBIO income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 4262000.00
HBIO balance_sheet (quarterly, 2025-06-30) — Goodwill: 10152000.00
HBIO balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 19291000.00
HBIO balance_sheet (quarterly, 2025-06-30) — Gross Accounts Receivable: 12101000.00
HBIO balance_sheet (quarterly, 2025-06-30) — Gross PPE: 12044000.00
HBIO income_statement (quarterly, 2025-06-30) — Gross Profit: 11533000.00
HBIO income_statement (quarterly, 2025-06-30) — Impairment Of Capital Assets: 0.00
HBIO cash_flow (quarterly, 2025-06-30) — Income Tax Paid Supplemental Data: 46000.00
HBIO income_statement (quarterly, 2025-06-30) — Interest Expense: 791000.00
HBIO income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 791000.00
HBIO cash_flow (quarterly, 2025-06-30) — Interest Paid Supplemental Data: 783000.00
HBIO balance_sheet (quarterly, 2025-06-30) — Inventory: 22255000.00
HBIO balance_sheet (quarterly, 2025-06-30) — Invested Capital: 50597000.00
HBIO cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -233000.00
HBIO cash_flow (quarterly, 2025-06-30) — Issuance Of Debt: 0.00
HBIO balance_sheet (quarterly, 2025-06-30) — Line Of Credit: 34864000.00
HBIO balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 6997000.00
HBIO balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 6997000.00
HBIO balance_sheet (quarterly, 2025-06-30) — Net Debt: 27422000.00
HBIO income_statement (quarterly, 2025-06-30) — Net Income: -2282000.00
HBIO income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -2282000.00
HBIO income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -2282000.00
HBIO income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -2282000.00
HBIO income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -2282000.00
HBIO cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -2282000.00
HBIO income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -2282000.00
HBIO income_statement (quarterly, 2025-06-30) — Net Interest Income: -791000.00
HBIO cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: 0.00
HBIO cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: -1000000.00
HBIO income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -791000.00
HBIO cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: -304000.00
HBIO balance_sheet (quarterly, 2025-06-30) — Net PPE: 12044000.00
HBIO cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -89000.00
HBIO cash_flow (quarterly, 2025-06-30) — Net Short Term Debt Issuance: 1000000.00
HBIO balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: -3558000.00
HBIO balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 734000.00
HBIO balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 734000.00
HBIO income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 353000.00
HBIO income_statement (quarterly, 2025-06-30) — Normalized Income: -2124000.00
HBIO cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 2755000.00
HBIO income_statement (quarterly, 2025-06-30) — Operating Income: -619000.00
HBIO income_statement (quarterly, 2025-06-30) — Operating Revenue: 20450000.00
HBIO balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 4453119.00
HBIO balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 3335000.00
HBIO balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 8896000.00
HBIO balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: -11702000.00
HBIO income_statement (quarterly, 2025-06-30) — Other Gand A: 4262000.00
HBIO income_statement (quarterly, 2025-06-30) — Other Income Expense: -844000.00
HBIO balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 9139000.00
HBIO cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 210000.00
HBIO balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 3789000.00
HBIO balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 1427000.00
HBIO income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: -644000.00
HBIO balance_sheet (quarterly, 2025-06-30) — Other Properties: 12044000.00
HBIO income_statement (quarterly, 2025-06-30) — Other Special Charges: 170000.00
HBIO balance_sheet (quarterly, 2025-06-30) — Payables: 4722000.00
HBIO balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 4722000.00
HBIO balance_sheet (quarterly, 2025-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 2124000.00
HBIO balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 0.00
HBIO income_statement (quarterly, 2025-06-30) — Pretax Income: -2254000.00
HBIO cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 46000.00
HBIO cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -89000.00
HBIO balance_sheet (quarterly, 2025-06-30) — Raw Materials: 14764000.00
HBIO balance_sheet (quarterly, 2025-06-30) — Receivables: 11937000.00
HBIO income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 8463000.00
HBIO income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 1616000.00
HBIO cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -1000000.00
HBIO income_statement (quarterly, 2025-06-30) — Research And Development: 2189000.00
HBIO income_statement (quarterly, 2025-06-30) — Restructuring And Mergern Acquisition: 30000.00
HBIO balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -210632000.00
HBIO cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 0.00
HBIO income_statement (quarterly, 2025-06-30) — Selling And Marketing Expense: 4539000.00
HBIO income_statement (quarterly, 2025-06-30) — Selling General And Administration: 8801000.00
HBIO balance_sheet (quarterly, 2025-06-30) — Share Issued: 4453119.00
HBIO cash_flow (quarterly, 2025-06-30) — Short Term Debt Issuance: 0.00
HBIO cash_flow (quarterly, 2025-06-30) — Short Term Debt Payments: 1000000.00
HBIO income_statement (quarterly, 2025-06-30) — Special Income Charges: -200000.00
HBIO cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 472000.00
HBIO balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 15733000.00
HBIO balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: -3558000.00
HBIO income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: -42000.00
HBIO income_statement (quarterly, 2025-06-30) — Tax Provision: 28000.00
HBIO income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.21
HBIO balance_sheet (quarterly, 2025-06-30) — Total Assets: 80093000.00
HBIO balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 15733000.00
HBIO balance_sheet (quarterly, 2025-06-30) — Total Debt: 43314000.00
HBIO balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 15733000.00
HBIO income_statement (quarterly, 2025-06-30) — Total Expenses: 21069000.00
HBIO balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 64360000.00
HBIO balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 35124000.00
HBIO balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 9158000.00
HBIO income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: -819000.00
HBIO income_statement (quarterly, 2025-06-30) — Total Unusual Items: -200000.00
HBIO income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: -200000.00
HBIO balance_sheet (quarterly, 2025-06-30) — Work In Process: 1556000.00
HBIO balance_sheet (quarterly, 2025-06-30) — Working Capital: -10233000.00
HBIO income_statement (quarterly, 2025-09-30) — +Operating Expense: 11776000.00
HBIO income_statement (quarterly, 2025-09-30) — +Total Revenue: 20591000.00
HBIO balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 5176000.00
HBIO balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 12109000.00
HBIO balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 237922000.00
HBIO balance_sheet (quarterly, 2025-09-30) — Allowance For Doubtful Accounts Receivable: -162000.00
HBIO income_statement (quarterly, 2025-09-30) — Amortization: 855000.00
HBIO cash_flow (quarterly, 2025-09-30) — Amortization Cash Flow: 899000.00
HBIO cash_flow (quarterly, 2025-09-30) — Amortization Of Intangibles: 899000.00
HBIO income_statement (quarterly, 2025-09-30) — Amortization Of Intangibles Income Statement: 855000.00
HBIO cash_flow (quarterly, 2025-09-30) — Asset Impairment Charge: 0.00
HBIO income_statement (quarterly, 2025-09-30) — Basic Average Shares: 4455600.00
HBIO income_statement (quarterly, 2025-09-30) — Basic EPS: -0.30
HBIO cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 7442000.00
HBIO cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -348000.00
HBIO cash_flow (quarterly, 2025-09-30) — Capital Expenditure Reported: -141000.00
HBIO balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 8818000.00
HBIO balance_sheet (quarterly, 2025-09-30) — Capital Stock: 446000.00
HBIO balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 6817000.00
HBIO balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 6817000.00
HBIO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -1278000.00
HBIO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -348000.00
HBIO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 1084000.00
HBIO cash_flow (quarterly, 2025-09-30) — Change In Account Payable: -271000.00
HBIO cash_flow (quarterly, 2025-09-30) — Change In Inventory: 637000.00
HBIO cash_flow (quarterly, 2025-09-30) — Change In Other Current Assets: 368000.00
HBIO cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: -234000.00
HBIO cash_flow (quarterly, 2025-09-30) — Change In Payable: -271000.00
HBIO cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: -271000.00
HBIO cash_flow (quarterly, 2025-09-30) — Change In Receivables: -210000.00
HBIO cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 290000.00
HBIO cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: -210000.00
HBIO cash_flow (quarterly, 2025-09-30) — Changes In Cash: -542000.00
HBIO balance_sheet (quarterly, 2025-09-30) — Common Stock: 446000.00
HBIO balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 14068000.00
HBIO income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 8570000.00
HBIO balance_sheet (quarterly, 2025-09-30) — Current Assets: 43805000.00
HBIO balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 1486000.00
HBIO balance_sheet (quarterly, 2025-09-30) — Current Debt: 33967000.00
HBIO balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 35453000.00
HBIO balance_sheet (quarterly, 2025-09-30) — Current Deferred Liabilities: 2879000.00
HBIO balance_sheet (quarterly, 2025-09-30) — Current Deferred Revenue: 2879000.00
HBIO balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 54396000.00
HBIO cash_flow (quarterly, 2025-09-30) — Deferred Income Tax: 20000.00
HBIO cash_flow (quarterly, 2025-09-30) — Deferred Tax: 20000.00
HBIO cash_flow (quarterly, 2025-09-30) — Depreciation: 425000.00
HBIO cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 1324000.00
HBIO income_statement (quarterly, 2025-09-30) — Depreciation Amortization Depletion Income Statement: 855000.00
HBIO cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 1324000.00
HBIO income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 855000.00
HBIO income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 4455600.00
HBIO income_statement (quarterly, 2025-09-30) — Diluted EPS: -0.30
HBIO income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -1231000.00
HBIO income_statement (quarterly, 2025-09-30) — EBIT: -168000.00
HBIO income_statement (quarterly, 2025-09-30) — EBITDA: 1156000.00
HBIO cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: -83000.00
HBIO cash_flow (quarterly, 2025-09-30) — End Cash Position: 6817000.00
HBIO cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -1278000.00
HBIO balance_sheet (quarterly, 2025-09-30) — Finished Goods: 5863000.00
HBIO cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 736000.00
HBIO balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: -12437000.00
HBIO income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 4176000.00
HBIO balance_sheet (quarterly, 2025-09-30) — Goodwill: 9525000.00
HBIO balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 17904000.00
HBIO balance_sheet (quarterly, 2025-09-30) — Gross Accounts Receivable: 12271000.00
HBIO balance_sheet (quarterly, 2025-09-30) — Gross PPE: 12490000.00
HBIO income_statement (quarterly, 2025-09-30) — Gross Profit: 12021000.00
HBIO income_statement (quarterly, 2025-09-30) — Impairment Of Capital Assets: 0.00
HBIO cash_flow (quarterly, 2025-09-30) — Income Tax Paid Supplemental Data: -2000.00
HBIO income_statement (quarterly, 2025-09-30) — Interest Expense: 966000.00
HBIO income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 966000.00
HBIO cash_flow (quarterly, 2025-09-30) — Interest Paid Supplemental Data: 967000.00
HBIO balance_sheet (quarterly, 2025-09-30) — Inventory: 21604000.00
HBIO balance_sheet (quarterly, 2025-09-30) — Invested Capital: 48035000.00
HBIO cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -348000.00
HBIO cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: 0.00
HBIO balance_sheet (quarterly, 2025-09-30) — Line Of Credit: 33967000.00
HBIO balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 7332000.00
HBIO balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 7332000.00
HBIO cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -1000000.00
HBIO balance_sheet (quarterly, 2025-09-30) — Net Debt: 27150000.00
HBIO income_statement (quarterly, 2025-09-30) — Net Income: -1231000.00
HBIO income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -1231000.00
HBIO income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -1231000.00
HBIO income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -1231000.00
HBIO income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -1231000.00
HBIO cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -1231000.00
HBIO income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -1231000.00
HBIO income_statement (quarterly, 2025-09-30) — Net Interest Income: -966000.00
HBIO cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: 0.00
HBIO cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: -1000000.00
HBIO cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: -1000000.00
HBIO income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -966000.00
HBIO cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: -278000.00
HBIO balance_sheet (quarterly, 2025-09-30) — Net PPE: 12490000.00
HBIO cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -207000.00
HBIO balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: -3836000.00
HBIO balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 733000.00
HBIO balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 733000.00
HBIO income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 1204000.00
HBIO income_statement (quarterly, 2025-09-30) — Normalized Income: -1193080.00
HBIO cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 1084000.00
HBIO income_statement (quarterly, 2025-09-30) — Operating Income: 245000.00
HBIO income_statement (quarterly, 2025-09-30) — Operating Revenue: 20591000.00
HBIO balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 4457966.00
HBIO balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 3275000.00
HBIO balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 9017000.00
HBIO balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: -12437000.00
HBIO income_statement (quarterly, 2025-09-30) — Other Gand A: 4176000.00
HBIO income_statement (quarterly, 2025-09-30) — Other Income Expense: -413000.00
HBIO balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 8379000.00
HBIO cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 357000.00
HBIO balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 3793000.00
HBIO balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 1463000.00
HBIO income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: -365000.00
HBIO balance_sheet (quarterly, 2025-09-30) — Other Properties: 12490000.00
HBIO balance_sheet (quarterly, 2025-09-30) — Payables: 5176000.00
HBIO balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 5176000.00
HBIO balance_sheet (quarterly, 2025-09-30) — Pensionand Other Post Retirement Benefit Plans Current: 1871000.00
HBIO balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 0.00
HBIO income_statement (quarterly, 2025-09-30) — Pretax Income: -1134000.00
HBIO cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 0.00
HBIO cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -207000.00
HBIO balance_sheet (quarterly, 2025-09-30) — Raw Materials: 13485000.00
HBIO balance_sheet (quarterly, 2025-09-30) — Receivables: 12109000.00
HBIO income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 8101000.00
HBIO income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 1324000.00
HBIO cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -1000000.00
HBIO income_statement (quarterly, 2025-09-30) — Research And Development: 2132000.00
HBIO income_statement (quarterly, 2025-09-30) — Restructuring And Mergern Acquisition: 48000.00
HBIO balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -211863000.00
HBIO cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 0.00
HBIO income_statement (quarterly, 2025-09-30) — Selling And Marketing Expense: 4613000.00
HBIO income_statement (quarterly, 2025-09-30) — Selling General And Administration: 8789000.00
HBIO balance_sheet (quarterly, 2025-09-30) — Share Issued: 4457966.00
HBIO income_statement (quarterly, 2025-09-30) — Special Income Charges: -48000.00
HBIO cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 324000.00
HBIO balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 14068000.00
HBIO balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: -3836000.00
HBIO income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: -10080.00
HBIO income_statement (quarterly, 2025-09-30) — Tax Provision: 97000.00
HBIO income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.21
HBIO balance_sheet (quarterly, 2025-09-30) — Total Assets: 77992000.00
HBIO balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 14068000.00
HBIO balance_sheet (quarterly, 2025-09-30) — Total Debt: 42785000.00
HBIO balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 14068000.00
HBIO income_statement (quarterly, 2025-09-30) — Total Expenses: 20346000.00
HBIO balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 63924000.00
HBIO balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 34187000.00
HBIO balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 9528000.00
HBIO income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: 197000.00
HBIO income_statement (quarterly, 2025-09-30) — Total Unusual Items: -48000.00
HBIO income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: -48000.00
HBIO balance_sheet (quarterly, 2025-09-30) — Work In Process: 2256000.00
HBIO balance_sheet (quarterly, 2025-09-30) — Working Capital: -10591000.00
HBIO income_statement (annual, 2025-12-31) — +Operating Expense: 49810000.00
HBIO income_statement (quarterly, 2025-12-31) — +Operating Expense: 12245000.00
HBIO income_statement (annual, 2025-12-31) — +Total Revenue: 86550000.00
HBIO income_statement (quarterly, 2025-12-31) — +Total Revenue: 23735000.00
HBIO balance_sheet (annual, 2025-12-31) — Accounts Payable: 3652000.00
HBIO balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 3652000.00
HBIO balance_sheet (annual, 2025-12-31) — Accounts Receivable: 16043000.00
HBIO balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 16043000.00
HBIO balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -18116000.00
HBIO balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -18116000.00
HBIO balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 239669000.00
HBIO balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 239669000.00
HBIO balance_sheet (annual, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -207000.00
HBIO balance_sheet (quarterly, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -207000.00
HBIO income_statement (annual, 2025-12-31) — Amortization: 4027000.00
HBIO income_statement (quarterly, 2025-12-31) — Amortization: 850000.00
HBIO cash_flow (annual, 2025-12-31) — Amortization Cash Flow: 4202000.00
HBIO cash_flow (quarterly, 2025-12-31) — Amortization Cash Flow: 894000.00
HBIO cash_flow (annual, 2025-12-31) — Amortization Of Intangibles: 4202000.00
HBIO cash_flow (quarterly, 2025-12-31) — Amortization Of Intangibles: 894000.00
HBIO income_statement (annual, 2025-12-31) — Amortization Of Intangibles Income Statement: 4027000.00
HBIO income_statement (quarterly, 2025-12-31) — Amortization Of Intangibles Income Statement: 850000.00
HBIO cash_flow (annual, 2025-12-31) — Asset Impairment Charge: 47951000.00
HBIO cash_flow (quarterly, 2025-12-31) — Asset Impairment Charge: 0.00
HBIO income_statement (annual, 2025-12-31) — Basic Average Shares: 4439100.00
HBIO income_statement (quarterly, 2025-12-31) — Basic Average Shares: 4460200.00
HBIO income_statement (annual, 2025-12-31) — Basic EPS: -12.80
HBIO income_statement (quarterly, 2025-12-31) — Basic EPS: -0.60
HBIO cash_flow (annual, 2025-12-31) — Beginning Cash Position: 4108000.00
HBIO cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 6817000.00
HBIO cash_flow (annual, 2025-12-31) — Capital Expenditure: -1863000.00
HBIO cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -599000.00
HBIO cash_flow (annual, 2025-12-31) — Capital Expenditure Reported: -605000.00
HBIO cash_flow (quarterly, 2025-12-31) — Capital Expenditure Reported: -150000.00
HBIO balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 8407000.00
HBIO balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 8407000.00
HBIO balance_sheet (annual, 2025-12-31) — Capital Stock: 447000.00
HBIO balance_sheet (quarterly, 2025-12-31) — Capital Stock: 447000.00
HBIO balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 8614000.00
HBIO balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 8614000.00
HBIO balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 8614000.00
HBIO balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 8614000.00
HBIO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -1291000.00
HBIO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 2449000.00
HBIO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -1863000.00
HBIO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -599000.00
HBIO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 6729000.00
HBIO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: -96000.00
HBIO cash_flow (annual, 2025-12-31) — Change In Account Payable: 2300000.00
HBIO cash_flow (quarterly, 2025-12-31) — Change In Account Payable: 797000.00
HBIO cash_flow (annual, 2025-12-31) — Change In Inventory: 2947000.00
HBIO cash_flow (quarterly, 2025-12-31) — Change In Inventory: 663000.00
HBIO cash_flow (annual, 2025-12-31) — Change In Other Current Assets: 1521000.00
HBIO cash_flow (quarterly, 2025-12-31) — Change In Other Current Assets: 1100000.00
HBIO cash_flow (annual, 2025-12-31) — Change In Other Working Capital: -161000.00
HBIO cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: 478000.00
HBIO cash_flow (annual, 2025-12-31) — Change In Payable: 2300000.00
HBIO cash_flow (quarterly, 2025-12-31) — Change In Payable: 797000.00
HBIO cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 2300000.00
HBIO cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 797000.00
HBIO cash_flow (annual, 2025-12-31) — Change In Receivables: -934000.00
HBIO cash_flow (quarterly, 2025-12-31) — Change In Receivables: -3956000.00
HBIO cash_flow (annual, 2025-12-31) — Change In Working Capital: 5673000.00
HBIO cash_flow (quarterly, 2025-12-31) — Change In Working Capital: -918000.00
HBIO cash_flow (annual, 2025-12-31) — Changes In Account Receivables: -934000.00
HBIO cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: -3956000.00
HBIO cash_flow (annual, 2025-12-31) — Changes In Cash: 3575000.00
HBIO cash_flow (quarterly, 2025-12-31) — Changes In Cash: 1754000.00
HBIO balance_sheet (annual, 2025-12-31) — Common Stock: 447000.00
HBIO balance_sheet (quarterly, 2025-12-31) — Common Stock: 447000.00
HBIO balance_sheet (annual, 2025-12-31) — Common Stock Equity: 13734000.00
HBIO balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 13734000.00
HBIO income_statement (annual, 2025-12-31) — Cost Of Revenue: 36640000.00
HBIO income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 9563000.00
HBIO balance_sheet (annual, 2025-12-31) — Current Assets: 48225000.00
HBIO balance_sheet (quarterly, 2025-12-31) — Current Assets: 48225000.00
HBIO balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 1525000.00
HBIO balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 1525000.00
HBIO balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 1525000.00
HBIO balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 1525000.00
HBIO balance_sheet (annual, 2025-12-31) — Current Deferred Liabilities: 3447000.00
HBIO balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 3447000.00
HBIO balance_sheet (annual, 2025-12-31) — Current Deferred Revenue: 3447000.00
HBIO balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 3447000.00
HBIO balance_sheet (annual, 2025-12-31) — Current Liabilities: 21960000.00
HBIO balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 21960000.00
HBIO cash_flow (annual, 2025-12-31) — Deferred Income Tax: -680000.00
HBIO cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: -127000.00
HBIO cash_flow (annual, 2025-12-31) — Deferred Tax: -680000.00
HBIO cash_flow (quarterly, 2025-12-31) — Deferred Tax: -127000.00
HBIO cash_flow (annual, 2025-12-31) — Depreciation: 1743000.00
HBIO cash_flow (quarterly, 2025-12-31) — Depreciation: 456000.00
HBIO cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 5945000.00
HBIO cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 1350000.00
HBIO income_statement (annual, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 4027000.00
HBIO income_statement (quarterly, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 850000.00
HBIO cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 5945000.00
HBIO cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 1350000.00
HBIO income_statement (annual, 2025-12-31) — Depreciation And Amortization In Income Statement: 4027000.00
HBIO income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 850000.00
HBIO income_statement (annual, 2025-12-31) — Diluted Average Shares: 4439100.00
HBIO income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 4460200.00
HBIO income_statement (annual, 2025-12-31) — Diluted EPS: -12.80
HBIO income_statement (quarterly, 2025-12-31) — Diluted EPS: -0.60
HBIO income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -56700000.00
HBIO income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -2847000.00
HBIO income_statement (annual, 2025-12-31) — EBIT: -52469000.00
HBIO income_statement (quarterly, 2025-12-31) — EBIT: -846000.00
HBIO income_statement (annual, 2025-12-31) — EBITDA: -46524000.00
HBIO income_statement (quarterly, 2025-12-31) — EBITDA: 504000.00
HBIO cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: 931000.00
HBIO cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: 43000.00
HBIO cash_flow (annual, 2025-12-31) — End Cash Position: 8614000.00
HBIO cash_flow (quarterly, 2025-12-31) — End Cash Position: 8614000.00
HBIO cash_flow (annual, 2025-12-31) — Financing Cash Flow: -1291000.00
HBIO cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 2449000.00
HBIO balance_sheet (annual, 2025-12-31) — Finished Goods: 5371000.00
HBIO balance_sheet (quarterly, 2025-12-31) — Finished Goods: 5371000.00
HBIO cash_flow (annual, 2025-12-31) — Free Cash Flow: 4866000.00
HBIO cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -695000.00
HBIO balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -11672000.00
HBIO balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -11672000.00
HBIO income_statement (annual, 2025-12-31) — General And Administrative Expense: 17742000.00
HBIO income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 4119000.00
HBIO balance_sheet (annual, 2025-12-31) — Goodwill: 9559000.00
HBIO balance_sheet (quarterly, 2025-12-31) — Goodwill: 9559000.00
HBIO balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 17198000.00
HBIO balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 17198000.00
HBIO balance_sheet (annual, 2025-12-31) — Gross Accounts Receivable: 16250000.00
HBIO balance_sheet (quarterly, 2025-12-31) — Gross Accounts Receivable: 16250000.00
HBIO balance_sheet (annual, 2025-12-31) — Gross PPE: 30075000.00
HBIO balance_sheet (quarterly, 2025-12-31) — Gross PPE: 30075000.00
HBIO income_statement (annual, 2025-12-31) — Gross Profit: 49910000.00